CAPRION PROTEOMICS INC has a total of 17 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2014. It filed its patents most often in EPO (European Patent Office), Hong Kong and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets measurement and environmental technology are LUSYS LABORATORIES INC, AUTOIMMUN DIAGNOSTIKA GMBH and BIOSYNEX.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Hong Kong | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 2 | |
#5 | United States | 2 | |
#6 | Australia | 1 | |
#7 | Israel | 1 | |
#8 | Japan | 1 | |
#9 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Paramithiotis Eustache | 15 |
#2 | Croteau Pascal | 14 |
#3 | Achkar Jacqueline Michele | 5 |
#4 | Madiraju S R Murthy | 3 |
#5 | Prentki Marc | 3 |
#6 | Lanoix Joel | 3 |
#7 | Joly Érik | 1 |
#8 | Rabasa-Lhoret Rémi | 1 |
#9 | Pascal Croteau | 1 |
#10 | Boom W Henry | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018013883A1 | Biomarkers of latent tuberculosis infection | |
AU2014233935A1 | Brucellosis, Q-Fever, and Lyme Disease biomarkers and uses thereof | |
WO2014133855A1 | Tuberculosis biomarkers and uses thereof | |
MX2015009940A | Type 2 diabetes biomarkers and uses thereof. |